VV. Advisory partners with life sciences start-ups and VC funds to accelerate — delivering valuation studies, investor materials, data rooms and strategic intelligence. On-demand. No overhead. No lock-in.
Your execution
partner in
life sciences.
VV. Advisory partners with life sciences start-ups and VC funds to accelerate — delivering valuation studies, investor materials, data rooms and strategic intelligence. On-demand. No overhead. No lock-in.
Our Expertise
Standalone DCF, rNPV modelling, comparable transactions, acquirer mapping across strategic buyer categories. Exit scenarios with sensitivity analyses — delivered as Excel model + investor presentation.
→End-to-end creation — structure, content, narrative flow, document production. Built to convert investor interest into conviction at every stage of due diligence.
→Short Deck (20p), Master Deck (50p), Two-pager, Annex Decks. Story-driven, investor-grade, co-built through structured iterations with your team.
→Structured databases of 200+ VC investors for start-ups and 300+ LPs for funds — institutional, HNWI, family offices, corporates — curated by sector, stage, and fit.
→Business plans, ecosystem mapping, strategic intelligence, external communications — any one-time execution need, scoped on demand.
All mandates delivered on a one-time or recurring basis — no retainer, no overhead, no lock-in.
Track Record
End-to-end investor pitch deck for Vetbiolix's Series B roadshow in veterinary drug development.
End-to-end data room — structure, content architecture, narrative flow and document production. Built to convert investor interest into conviction at every stage of due diligence.
200+ international VC funds identified with key contacts and direct emails for a health start-up's $20M+ fundraising round.
Structured database of 300+ institutional LPs — family offices, corporates, HNWI — for a healthcare VC fund's €100M fundraising round.
Client Testimonial
The collaboration with Victor went seamlessly in the context of optimising our corporate documents for our Series B roadshow in veterinary drug development. His ability to rapidly grasp the strategic stakes of Vetbiolix, then produce content that was both sharp and compelling, proved invaluable. His strong command of VC expectations in global life sciences significantly improved the clarity and impact of the investment case we presented.
Currently active
More mandates
in progress.
Additional references and case studies available upon request.
Request referencesLet's work together
Tell us about your mandate — valuation, pitch deck, data room, investor mapping. We scope fast and start faster.
Send a brief →